WO2009108168A3 - Gold nanoparticle glycoconjugates for generating igg specific for the carbohydrate - Google Patents
Gold nanoparticle glycoconjugates for generating igg specific for the carbohydrate Download PDFInfo
- Publication number
- WO2009108168A3 WO2009108168A3 PCT/US2008/012692 US2008012692W WO2009108168A3 WO 2009108168 A3 WO2009108168 A3 WO 2009108168A3 US 2008012692 W US2008012692 W US 2008012692W WO 2009108168 A3 WO2009108168 A3 WO 2009108168A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gold nanoparticle
- glycoconjugates
- carbohydrate
- igg specific
- generating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
A composition can include a gold nanoparticle and a peptide and an oligosaccharide bound to the gold nanoparticle. The oligosaccharide can be an antigen, so that the composition can be used to induce an immunogenic response.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98722407P | 2007-11-12 | 2007-11-12 | |
US60/987,224 | 2007-11-12 | ||
US8377308P | 2008-07-25 | 2008-07-25 | |
US61/083,773 | 2008-07-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009108168A2 WO2009108168A2 (en) | 2009-09-03 |
WO2009108168A3 true WO2009108168A3 (en) | 2009-12-30 |
Family
ID=41016632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/012692 WO2009108168A2 (en) | 2007-11-12 | 2008-11-12 | Gold nanoparticle glycoconjugates for generating igg specific for the carbohydrate |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009108168A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512755B2 (en) | 2011-08-15 | 2013-08-20 | The United States Of America, As Represented By The Secretary Of The Navy | Compact multifunctional ligand to enhance colloidal stability of nanoparticles |
GB201003088D0 (en) * | 2010-02-24 | 2010-04-14 | Univ Exeter | Method for the preparation of a novel nanoparticle conjugate |
CN110935030B (en) * | 2019-11-13 | 2023-01-10 | 南方科技大学 | Gold nanocluster and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040115214A1 (en) * | 1998-01-13 | 2004-06-17 | Xin-Xing Gu | Lipooligosaccharide-based vaccine for prevention of Moraxella (Branhamella) catarrhalis infections in humans |
US20050049197A1 (en) * | 1993-09-14 | 2005-03-03 | Epimmune Inc. | Induction of immune response against desired determinants |
US20050142539A1 (en) * | 2002-01-14 | 2005-06-30 | William Herman | Targeted ligands |
WO2005111196A1 (en) * | 2004-05-14 | 2005-11-24 | National Research Council Canada | Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
US20070249063A1 (en) * | 2004-08-30 | 2007-10-25 | Deshong Philip R | Biosensors |
-
2008
- 2008-11-12 WO PCT/US2008/012692 patent/WO2009108168A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050049197A1 (en) * | 1993-09-14 | 2005-03-03 | Epimmune Inc. | Induction of immune response against desired determinants |
US20040115214A1 (en) * | 1998-01-13 | 2004-06-17 | Xin-Xing Gu | Lipooligosaccharide-based vaccine for prevention of Moraxella (Branhamella) catarrhalis infections in humans |
US20050142539A1 (en) * | 2002-01-14 | 2005-06-30 | William Herman | Targeted ligands |
WO2005111196A1 (en) * | 2004-05-14 | 2005-11-24 | National Research Council Canada | Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
US20070249063A1 (en) * | 2004-08-30 | 2007-10-25 | Deshong Philip R | Biosensors |
Also Published As
Publication number | Publication date |
---|---|
WO2009108168A2 (en) | 2009-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007106744A3 (en) | Anti-5t4 antibodies and uses thereof | |
MY171841A (en) | Antibody formulation | |
NO20085396L (en) | Antibodies and immune conjugates, and uses thereof | |
EP2368913A3 (en) | Glyco-engineered antibodies | |
WO2007079190A3 (en) | Device and method for enhancing immune response by electrical stimulation | |
WO2008021076A3 (en) | Protein matrix vaccines and methods of making and administering such vaccines | |
WO2009128952A3 (en) | Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof | |
IN2012DN04908A (en) | ||
NO20092052L (en) | Antibodies and immune conjugates, and uses thereof | |
FR2919804B1 (en) | COMPOSITION AND ANTI-TUMOR THERAPEUTIC VACCINE | |
WO2006082406A3 (en) | Human antibodies and proteins | |
WO2006132670A3 (en) | Auristatins having an aminobenzoic acid unit at the n terminus | |
WO2007050656A3 (en) | Dietary fiber formulation and method of administration | |
IL223473A0 (en) | Compression device , system for improving blood flow in the limb | |
IL191911A (en) | Immunogenic composition comprising s. pneumoniae capsular saccharide conjugates and various aspects related thereto | |
WO2007111940A3 (en) | Regimens for immunisation with meningococcal conjugates | |
IL222792A0 (en) | Method of coupling an oligosaccharide to a protein, oligosaccharide-protein conjugates, uses thereof and pharmaceutical compositions comprising the same | |
NO20084356L (en) | Anti TAT226 antibodies and immunoconjugates | |
WO2009092011A8 (en) | Cysteine engineered antibodies for site-specific conjugation | |
WO2009114040A3 (en) | Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses | |
ZA200902697B (en) | Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses | |
WO2008020322A3 (en) | Combination vaccines with 1-hydroxy-2-phenoxyethane preservative | |
WO2008063982A3 (en) | High mannose glycoprotein epitopes | |
WO2009046015A3 (en) | Combination therapies for treating type 1 diabetes | |
WO2005122739A3 (en) | Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08872817 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08872817 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |